Close Menu

Daniel at the Genetic Future welcomes a dissenting view to the Genetic Information Nondiscrimination Act, which has gone through various stages of approval in US Congress but hasn't officially made it into law. While it "appears to be almost universally regarded as a good thing," Daniel writes, he says he was glad to see a well-reasoned consideration of the opposing view in a letter to Nature from Marcelino Fuentes. Fuentes writes:

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.